Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Oric closes funding to develop glucocorticoid antagonist ORIC-101

pharmaceutical-technologyAugust 12, 2019

Tag: Development , ORIC , glucocorticoid antagonist

PharmaSources Customer Service